Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin S Murnane

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Progress in Brain Research|November 26, 2018
The renaissance in psychedelic research: What do preclinical models have to offerKevin S Murnane
Journal of Psychopharmacology (Oxford, England)|December 2, 2016
The serotonin 5-HT<sub>2C</sub> receptor and the non-addictive nature of classic hallucinogensClinton E Canal, Kevin S Murnane
European Journal of Pharmacology|November 10, 2018
The serotonin 2C receptor agonist WAY-163909 attenuates ketamine-induced hypothermia in miceTyler J Murphy, Kevin S Murnane
Psychopharmacology|March 2, 2011
Neuroimaging and drug taking in primatesKevin S Murnane, Leonard L Howell
Annals of the New York Academy of Sciences|November 11, 2008
Nonhuman primate neuroimaging and the neurobiology of psychostimulant addictionLeonard L Howell, Kevin S Murnane
Currents in Pharmacy Teaching & Learning|October 25, 2022
Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of dataKevin S Murnane, Jill M Augustine, Leisa L Marshall
International Journal of Pharmaceutics|November 16, 2020
Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depressionSonalika A Bhattaccharjee, Kevin S Murnane, Ajay K Banga
Psychopharmacology|January 23, 2021
MDPV "high-responder" rats also self-administer more oxycodone than their "low-responder" counterparts under a fixed ratio schedule of reinforcementBrenda M Gannon, Kenner C Rice, Kevin S Murnane
CNS & Neurological Disorders Drug Targets|November 15, 2019
Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative DisordersNeha M Chitre, Nader H Moniri, Kevin S Murnane
Biochemical Pharmacology|November 6, 2007
The behavioral pharmacology of hallucinogensWilliam E Fantegrossi, Kevin S Murnane, Chad J Reissig
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Progress in Brain Research|November 26, 2018
The renaissance in psychedelic research: What do preclinical models have to offerKevin S Murnane
Journal of Psychopharmacology (Oxford, England)|December 2, 2016
The serotonin 5-HT<sub>2C</sub> receptor and the non-addictive nature of classic hallucinogensClinton E Canal, Kevin S Murnane
European Journal of Pharmacology|November 10, 2018
The serotonin 2C receptor agonist WAY-163909 attenuates ketamine-induced hypothermia in miceTyler J Murphy, Kevin S Murnane
Psychopharmacology|March 2, 2011
Neuroimaging and drug taking in primatesKevin S Murnane, Leonard L Howell
Annals of the New York Academy of Sciences|November 11, 2008
Nonhuman primate neuroimaging and the neurobiology of psychostimulant addictionLeonard L Howell, Kevin S Murnane
Currents in Pharmacy Teaching & Learning|October 25, 2022
Student pharmacists' attitudes, perceptions, and knowledge regarding opioid use, misuse, and overdose: Four years of dataKevin S Murnane, Jill M Augustine, Leisa L Marshall
International Journal of Pharmaceutics|November 16, 2020
Transdermal delivery of breakthrough therapeutics for the management of treatment-resistant and post-partum depressionSonalika A Bhattaccharjee, Kevin S Murnane, Ajay K Banga
Psychopharmacology|January 23, 2021
MDPV "high-responder" rats also self-administer more oxycodone than their "low-responder" counterparts under a fixed ratio schedule of reinforcementBrenda M Gannon, Kenner C Rice, Kevin S Murnane
CNS & Neurological Disorders Drug Targets|November 15, 2019
Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative DisordersNeha M Chitre, Nader H Moniri, Kevin S Murnane
Biochemical Pharmacology|November 6, 2007
The behavioral pharmacology of hallucinogensWilliam E Fantegrossi, Kevin S Murnane, Chad J Reissig
Pageof 9